These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11886466)

  • 1. Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.
    Ashrani AA; Reding MT; Greeno EW; Shet A; Key NS
    Haemophilia; 2002 Jan; 8(1):56-8. PubMed ID: 11886466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of spontaneous inhibitors in children with porcine factor VIII.
    Kobrinsky NL; Stegman D; Sjolander D
    Haemophilia; 2002 Jan; 8 Suppl 1():1-4; discussion 28-32. PubMed ID: 11882074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experience.
    O'Gorman P; Dimichele DM; Kasper CK; Mannucci PM; Santagostini E; Hay CR
    Haemophilia; 2001 Nov; 7(6):537-43. PubMed ID: 11851750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant B-domain-deleted porcine sequence factor VIII (r-pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors.
    Mahlangu JN; Andreeva TA; Macfarlane DE; Walsh C; Key NS
    Haemophilia; 2017 Jan; 23(1):33-41. PubMed ID: 27761964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor.
    Croteau SE; Abajas YL; Wolberg AS; Nielsen BI; Marx GR; Baird CW; Neufeld EJ; Monahan PE
    Haemophilia; 2017 Mar; 23(2):e93-e98. PubMed ID: 28124406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine factor VIII in the treatment of high-titre inhibitor patients.
    Garvey MB
    Haemophilia; 2002 Jan; 8 Suppl 1():5-8; discussion 28-32. PubMed ID: 11882075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.
    Kruse-Jarres R; St-Louis J; Greist A; Shapiro A; Smith H; Chowdary P; Drebes A; Gomperts E; Bourgeois C; Mo M; Novack A; Farin H; Ewenstein B
    Haemophilia; 2015 Mar; 21(2):162-170. PubMed ID: 25623166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine factor VIII: pharmacoeconomics of inhibitor therapy.
    Ewenstein BM; Avorn J; Putnam KG; Bohn RL
    Haemophilia; 2002 Jan; 8 Suppl 1():13-6; discussion 28-32. PubMed ID: 11882077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.
    Fosbury E; Drebes A; Riddell A; Chowdary P
    Ther Adv Hematol; 2017 Sep; 8(9):263-272. PubMed ID: 29051804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C).
    Freedman J; Mody M; Lazarus AH; Dewar L; Song S; Blanchette VS; Garvey MB; Ofosu FA
    Am J Hematol; 2002 Mar; 69(3):192-9. PubMed ID: 11891806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acquired haemophilia].
    Buczma A; Windyga J
    Pol Arch Med Wewn; 2007; 117(5-6):241-5. PubMed ID: 18030874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure in acquired haemophilia following the use of high dose intravenous immunoglobulin.
    Laidlaw S; Bainton R; Wilkie M; Makris M
    Haemophilia; 1999 Jul; 5(4):270-2. PubMed ID: 10469182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
    Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
    Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine factor VIII provides clinical benefit to patients with high levels of inhibitors to human and porcine factor VIII.
    Gribble J; Garvey MB
    Haemophilia; 2000 Sep; 6(5):482-5. PubMed ID: 11012689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acquired haemophilia A--more questions than answers.
    Collins PW
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S23-7. PubMed ID: 14567531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Protein-A column and porcine factor VIII.
    Rivard GE
    Haemophilia; 2002 Jan; 8 Suppl 1():20-3; discussion 28-32. PubMed ID: 11882079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.